In our study, pDCs showed higher activation and better effector function in the TME of MIP treated mice but no change was observed in their frequency or infiltration in the tumor, suggesting a potent role of MIP in remodulation of the phenotype and function of the tumor resident pDCs. The gene discussed is MIP; the disease is neoplasm.